Point-of-care (POC) testing is rapidly expanding in clinical settings, serving as a critical tool for a range of medical conditions, from respiratory tract infections to other infectious diseases. By shifting diagnostics closer to the patient, decentralized healthcare settings can now address a broader spectrum of acute and routine clinical needs concurrently. While managing respiratory pathogens such as respiratory syncytial virus (RSV) highlights the multi-faceted benefits of this immediacy, the true value of POC testing lies in how it redefines clinical workflows. Even when targeted pharmaceutical interventions are not indicated for a specific positive result, the information provided by rapid testing extends far beyond a prescribed treatment.

In emergency departments, urgent care clinics, physician offices, and other community care settings, rapid diagnostics support real-time case management, inform bed placement and isolation decisions, expedite triage and improve operational efficiency. As respiratory seasons have become increasingly complex, POC testing helps clinicians move beyond overlapping clinical presentations to make targeted patient management decisions. Across all care settings, timely and accurate diagnostic information ultimately improves both the patient experience and the efficiency of modern healthcare delivery systems.

Supporting busy emergency departments

Emergency department (ED) boarding and crowding are increasingly recognized as a public health emergency.¹  While the causes are multifactorial and solutions remain complex, molecular point-of-care (mPOC) testing can play a meaningful role in helping ED staff triage and manage patients more efficiently.

For respiratory infections such as RSV, molecular POC testing can deliver results in less than thirty minutes, reducing diagnostic uncertainty and accelerating clinical decision-making to expedite safe discharge or admission pathways, while informing critical choices around isolation and bed placement. In today’s era, when infectious pathogens such as influenza, COVID-19, and RSV frequently circulate simultaneously, rapid testing helps healthcare providers differentiate among overlapping clinical symptoms and complex patient presentations.

This same diagnostic framework is increasingly valuable when addressing other compounding public health challenges in outpatient care. With more than 2 million STI ² cases reported annually in the United States, expanding mPOC testing into sexual health can help clinicians deliver rapid, same-visit diagnoses. Providing clarity in these encounters not only supports the linkage to appropriate individual care but also supports crucial public health efforts to interrupt transmission chains across communities.  

This diagnostic certainty can have significant downstream benefits by reducing the need for reflex or duplicative testing while helping guide treatment decisions earlier in the patient encounter. In turn, faster and more targeted decision-making may contribute to total cost avoidance by helping to limit further unnecessary testing, reduce repeat visits, and optimize overall hospital resource utilization

Timely results in urgent care clinics

In urgent care environments, speed and simplicity are essential pillars for customer satisfaction. A recent study published in the Journal of Urgent Care Medicine found that visit duration was the greatest predictor of customer satisfaction.³ Achieving this efficiency helps support business success and a sustainable business model.

Patients increasingly expect definitive answers during a single visit, particularly when the onset of respiratory symptoms disrupts work, school, or caregiving responsibilities. To help meet this need, point-of-care testing for pathogens like RSV can help clinicians quickly confirm a viral etiology or rule it out—without delay in care.  Having timely, accurate results improves throughput during peak respiratory season while creating a smoother, more efficient care experience overall.

At the population health level, rapid diagnostic clarity plays a vital role in antimicrobial stewardship, particularly because an estimated 85–95% of antibiotic prescriptions are written in outpatient settings, with approximately 30% of these prescriptions unnecessary. Because acute respiratory infections (ARI’s) account for roughly 40% of all antibiotics prescribed to adults in these environments, identifying a viral illness should be a critical priority.^1,3  High-quality mPOC testing acts as a clinical brake: it interrupts assumptions and habitual prescribing patterns with objective information, giving clinicians and patients greater confidence to wait and watch when appropriate. Because these systems are designed for ease of use and don’t require extensive laboratory infrastructure, urgent care and retail clinics can expand access to molecular diagnostics across many different disease areas, allowing clinics to deliver comprehensive same-visit care.

In-house testing at physicians’ offices

Physicians’ offices represent another rapidly expanding setting for molecular point-of-care testing.  Performing testing on site rather than sending samples to an external laboratory can accelerate clinical conversations, improve continuity of care, and streamline patient workflows.

For pediatric practices in particular, rapid RSV results are critical, as young patients can decompensate rapidly. Because RSV is the primary etiology in the vast majority of infant bronchiolitis presentations,⁴ accurate viral diagnosis helps clinicians assess risk early and confidently counsel caregivers about symptom monitoring, supportive measures, and when escalation of care may be necessary.

As with other care settings, keeping diagnostics at the point of care drives operational efficiency by mitigating the need for retrospective treatment adjustments and unnecessary return visits. Ultimately, replacing clinical uncertainty with timely results provides patients with the confidence and clarity they seek during a visit.

The expanding role of multiplex testing

The clinical utility of point-of-care testing reaches its full potential through multiplex diagnostic strategies that reflect both the expanding care settings and broader spectrum of disease areas. Just as POC platforms have successfully migrated from traditional laboratories into diverse clinical environments, the technology itself is expanding beyond single-pathogen detection. Multiplex assays arm providers with more comprehensive results from a single patient sample––whether they’re navigating complex overlapping respiratory symptoms like RSV, influenza and COVID-19 or time-sensitive infectious diseases, such as sexually transmitted infections. Rather than requiring clinicians to rely on empirical treatment, this multi-pathogen capability provides immediate clarity.

Modern testing protocols and algorithms must adapt to developing viral epidemiology and shifting clinical needs. Recent trends have proven that respiratory infections are no longer strictly confined to traditional winter windows; unexpected off-season surges require vigilant, year-round diagnostic readiness. By adopting multi- pathogen and multi-disease POC testing as an objective, year-round standard, expanding healthcare networks can confidently manage unpredictable viral circulation, streamline pathways and ensure precise clinical decision-making exactly when and where the patient seeks care.

Point-of-care testing is about more than diagnosis

The true value of mPOC extends far beyond individual patient encounters. By integrating timely and accurate diagnostics directly into frontline clinical workflows, health systems have the opportunity to further achieve operational excellence, advance antibiotic stewardship and elevate the standard for patient and consumer satisfaction. It’s not a matter of just a nice-to-know result, it’s a need to know.

The widespread adoption of these platforms is a foundational shift toward proactive public health management of infectious diseases. Whether managing unpredictable respiratory surges or routing critical sexual health results, bringing diagnostics to the patient encounter fundamentally changes how care is delivered. Embracing this technology ensures that various healthcare settings remain resilient, resources are used efficiently and the families within our communities receive the timely and confident care they are seeking and healthcare professionals want to provide.

REFERENCES

1. Emergency department boarding and crowding. American College of Emergency Physicians. Accessed August 6, 2026. https://www.acep.org/administration/crowding--boarding.
2. Stoner, B. CDC releases 2024 national STI data. CDC. September 24, 2025. Accessed August 6, 2026. https://www.cdc.gov/nchhstp/director-letters/release-2024-sti-data.html.
3. Ayers, A. Shorter visits drive greater patient satisfaction in urgent care. The Journal of Urgent Care Medicine. February 27, 2025. Accessed August 6, 2026. https://www.jucm.com/shorter-visits-drive-greater-patient-satisfaction-in-urgent-care/.
4. Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev. 2014;35(12):519-30. doi:10.1542/pir.35-12-519.